Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 2
2006 3
2008 2
2009 4
2010 1
2012 3
2013 2
2014 1
2015 2
2016 3
2017 2
2018 1
2019 4
2020 3
2021 7
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Desmoglein-2 as a cancer modulator: friend or foe?
Myo Min KK, Ffrench CB, McClure BJ, Ortiz M, Dorward EL, Samuel MS, Ebert LM, Mahoney MG, Bonder CS. Myo Min KK, et al. Among authors: ebert lm. Front Oncol. 2023 Dec 22;13:1327478. doi: 10.3389/fonc.2023.1327478. eCollection 2023. Front Oncol. 2023. PMID: 38188287 Free PMC article. Review.
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.
Stringer BW, De Silva MI, Greenberg Z, Noreña Puerta A, Adams R, Milky B, Zabolocki M, van den Hurk M, Ebert LM, Fairly Bishop C, Conn SJ, Kichenadasse G, Michael MZ, Ormsby RJ, Poonoose S, Bardy C. Stringer BW, et al. Among authors: ebert lm. Sci Adv. 2023 Oct 27;9(43):eadf1332. doi: 10.1126/sciadv.adf1332. Epub 2023 Oct 25. Sci Adv. 2023. PMID: 37878712 Free PMC article.
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
Gargett T, Ebert LM, Truong NTH, Kollis PM, Sedivakova K, Yu W, Yeo ECF, Wittwer NL, Gliddon BL, Tea MN, Ormsby R, Poonnoose S, Nowicki J, Vittorio O, Ziegler DS, Pitson SM, Brown MP. Gargett T, et al. Among authors: ebert lm. J Immunother Cancer. 2022 Sep;10(9):e005187. doi: 10.1136/jitc-2022-005187. J Immunother Cancer. 2022. PMID: 36167468 Free PMC article.
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.
Pickering C, Aiyetan P, Xu G, Mitchell A, Rice R, Najjar YG, Markowitz J, Ebert LM, Brown MP, Tapia-Rico G, Frederick D, Cong X, Serie D, Lindpaintner K, Schwarz F, Boland GM. Pickering C, et al. Among authors: ebert lm. Front Immunol. 2023 Jun 14;14:1187332. doi: 10.3389/fimmu.2023.1187332. eCollection 2023. Front Immunol. 2023. PMID: 37388743 Free PMC article.
53 results